Mumbai, February 9, 2026 : Dr. Chirag Jain spent 18 years as a surgeon watching cancer
destroy not just bodies, but souls. Today, he's building what could become the
most significant transformation in oncology care since chemotherapy itself.
This isn't incremental improvement. This is a paradigm
shift worth billions.
Mindful Gurukul Private Limited announced breakthrough
clinical validation results and ₹4 crore investment from a US-based angel
investor for Skitii – a
patented AI music therapy platform that provides significant pain relief for
cancer patients. But the real story? Dr. Jain is positioning this technology to
reach every cancer treatment center on the planet.
The Billion-Dollar Opportunity: Transforming
Oncology Care
Globally, 20 million people are diagnosed with cancer
annually. Each undergoes months of treatment. Each experiences debilitating
pain and emotional trauma. The current solution? Opioids with devastating side
effects, or nothing at all.
"We're not building a feature for cancer care –
we're rebuilding the foundation of how oncology treats the whole patient,"
Dr. Jain declared. "This is a multi-billion dollar market that nobody has
cracked because you need both deep clinical expertise AND cutting-edge AI
innovation. We have both."
The global pain management market is valued at $85
billion. Music therapy for healthcare? Barely explored at scale. AI-powered
adaptive systems for cancer care? Dr. Jain's company is pioneering the
category.
"This is the million-dollar idea – actually, the
billion-dollar transformation," he said. "First mover advantage in a
massive market where we're creating the category itself."
The Surgeon Who Saw What Others Missed
After 18+ years in surgery, Dr. Jain recognized what
pharmaceutical companies and medical device giants overlooked: cancer patients
don't just need drugs – they need emotional support that scales, that's
available 24/7, that adapts to their individual suffering.
"As a surgeon, I could only be with patients for
minutes. But their suffering lasted hours, days, months," Dr. Jain
explained. "I realized the breakthrough wouldn't come from better surgery
– it would come from technology that could provide compassionate presence when
humans couldn't."
So he stopped operating and started building the
future of oncology care.
The Patented Technology That Changes Everything
Skitii isn't just a music app. It's a medical device
that uses proprietary patented algorithms to create personalized therapeutic
music that adapts to each patient's unique physiological and emotional needs
during cancer treatment.
The platform continuously monitors patients through
advanced biometric sensing and responds dynamically when distress is detected –
delivering precisely calibrated therapeutic interventions through sound.
Patented. Proven. Ready to Scale.
- Indian
patents secured – international PCT applications
filed for global protection
- Clinical
validation – significant pain reduction
demonstrated in trials
- US
investor backing – ₹4 crore validates
global market potential
- DPIIT
recognition – government-validated
healthcare innovation
- CDSCO
approval in progress – Class B medical
device regulatory pathway
"This is patented technology being built in India
to export to the world," Dr. Jain emphasized. "Under Prime Minister
Modi's vision for healthcare self-reliance and innovation, Indian startups can
dominate global healthcare markets. We're proving it."
Why This Attracts Global Capital
US-based seasoned Angel investor committed ₹4 crore
because they see what Dr. Jain sees: a massive underserved market, proprietary
patented technology, a founder who deeply understands the clinical problem, and
a clear path to becoming the standard of care in oncology centers worldwide.
"International investors don't fund incremental
improvements," Dr. Jain noted. "They fund transformation. They fund
founders who can execute billion-dollar visions with defensible intellectual
property. That's what we're building."
Join the Transformation
Dr. Jain is assembling a world-class team to execute
this vision. Not just employees – co-creators of the future of cancer care.
Who Transforms Oncology with Dr. Jain:
Innovators & Builders: "I need people who want to build technology that reaches
20 million patients, not 20,000 users" – Dr. Jain
- AI/ML
engineers passionate about healthcare applications
- Medical
device software architects
- Algorithm
developers with therapeutic technology experience
- Full-stack
developers who understand clinical workflows
Clinical Visionaries: "Oncologists
who understand we're not disrupting their work – we're multiplying their
impact" – Dr. Jain
- Forward-thinking
hospital administrators
- Cancer
care centers ready to pioneer transformation
- Clinicians
who see beyond today's protocols
Strategic Empire-Builders:
- Medical
device distributors for 50+ country expansion
- Healthcare
investors who fund category creation
- Regulatory
experts who navigate global approvals
- Business
development leaders who close hospital partnerships at scale
Why Join a Surgeon-Founder Building a
Billion-Dollar Vision?
Dr. Jain brings what tech founders can't replicate:
18+ years of clinical credibility, hospital operations expertise, deep
understanding of oncology workflows, and genuine patient empathy. Plus the
founder's hunger to build something massive.
"I didn't leave surgery to build a small
company," he said. "I left to transform how humanity treats cancer.
That requires people who think bigger than anyone else in the room."
The Traction Proving the Vision
- Clinical
impact: Patients reporting significant
pain reduction and emotional relief
- Regulatory
momentum: CDSCO Class B approval pathway
established
- IP
fortress: Indian patents secured +
international PCT applications = defensible moat
- Capital
validation: ₹4 crore from sophisticated
US investors
- Market
expansion: Clinical validation expanding,
global pipeline building
"This isn't a side feature oncologists might
adopt," Dr. Jain explained. "This becomes as fundamental to cancer
treatment as imaging or diagnostic testing. That's billion-dollar
transformation."
From India to Every Cancer Center on Earth
This is India's moment. Not just consuming Western
healthcare technology – exporting Indian innovation globally. A surgeon-founder
building patented AI systems that solve problems Silicon Valley missed.
International capital backing Indian execution.
"We're proving Indian startups can lead
categories, not just participate," Dr. Jain said. "Cancer doesn't
care about borders. Neither does our ambition."
The Personal Mission Driving Billions
"A patient undergoing chemotherapy told me the
music felt like someone holding her hand," Dr. Jain shared. "That
moment – when technology delivers humanity at scale – that's what drives me.
Not the valuation. Not the market size. The knowledge that we're reducing
suffering for millions of people who have no other option."
The Invitation
Dr. Jain is personally engaging with exceptional
talent and visionary partners. This is the inflection point. Clinical
validation advancing. Capital secured. Patents filed. Regulatory pathway clear.
Market massive. Founder proven.
"If you want to work on incremental improvements,
there are thousands of startups," Dr. Jain concluded. "If you want to
transform a $85 billion market and actually change how humanity treats cancer
with proprietary patented technology – reach out. Let's build this empire
together."
Contact Dr. Chirag Jain Directly: CEO & Co-founder, Mindful Gurukul Private Limited
Email id : chiragjain@minfulgurukul.com
Linkedin: https://www.linkedin.com/in/dr-chirag-jain/
About Dr. Chirag Jain & Mindful Gurukul Dr. Chirag Jain is a surgeon-turned-founder with 18+ years
clinical experience, now leading the transformation of global oncology care.
Mindful Gurukul Private Limited is a DPIIT-recognized, Mumbai-based healthcare
technology startup building patented AI-powered therapeutic solutions for
worldwide export. With secured Indian patents, international PCT applications,
US angel investment backing, and clinical validation results, the company is
positioned to become the standard of care in cancer treatment centers globally
– serving 20 million+ patients annually and creating a billion-dollar category
in adaptive AI therapeutics.